Annual EBITDA
$4.98B$832.89M+20.06%
Summary
- Current Value
- As of today, COR annual EBITDA is $4.98B, up +20.06% on
- Historical Performance
- COR annual EBITDA is up +44.50% over the past 3 years, up +105.46% over the past 5 years
- All-Time High Comparison
- COR annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- COR annual EBITDA is +45.80% above its 3-year low of $3.42B reached on
- Sector Comparison
- COR annual EBITDA is higher than 97.62% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $4.98B | +20.1% | +44.5% | +105.5% | +319.7% | |
| Quarterly EBITDA | $1.47B | +18.6% | +74.7% | +31.1% | +324.6% | |
| TTM EBITDA | $5.46B | +20.2% | +63.1% | +66.5% | +310.2% | |
| Price | $310.81 | +6.8% | +65.9% | +159.9% | +711.5% | |
| PE Ratio | 23.11 | -22.8% | +1.2% | – | +50.9% | |
| Annual Revenue | $321.33B | +9.3% | +34.7% | +69.2% | +312.2% | |
| Annual EPS | $7.96 | +5.7% | -1.0% | +147.8% | +258.6% | |
| $3.93B | +29.4% | +43.0% | +94.3% | +261.4% | ||
| Annual Net Income | $1.57B | +3.2% | -5.9% | +146.1% | +146.2% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $4.98B | at high | |
| 5Y | $4.98B | at high | |
| All | $4.98B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $3.42B | +45.8% | |
| 5Y | $2.43B | N/A | +105.5% |
| All | $92.60M | +5283.0% |
EBITDA History
FAQ
- What is the current annual EBITDA of COR?
- As of today, COR annual EBITDA is $4.98B
- What is 1-year change in COR annual EBITDA?
- COR annual EBITDA is up +20.06% year-over-year
- What is 3-year change in COR annual EBITDA?
- COR annual EBITDA is up +44.50% over the past 3 years
- How far is COR annual EBITDA from its all-time high?
- COR annual EBITDA is currently at its all-time high
- How does COR annual EBITDA rank versus sector peers?
- COR annual EBITDA is higher than 97.62% of companies in Healthcare sector
- When is COR next annual earnings release?
- The next annual earnings release for COR is on
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$1.47B$131.68M-8.21%
Summary
- Current Value
- As of today, COR quarterly EBITDA is $1.47B, down -8.21% on
- Historical Performance
- COR quarterly EBITDA is up +18.60% year-over-year, up +74.69% over the past 3 years
- All-Time High Comparison
- COR quarterly EBITDA is currently -8.21% below its historical high of $1.60B set on
- 3-Year Low Comparison
- COR quarterly EBITDA is +86.65% above its 3-year low of $789.04M reached on
- Sector Comparison
- COR quarterly EBITDA is higher than 97.51% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.47B | -8.2% | +18.6% | +74.7% | +31.1% | |
| Annual EBITDA | $4.98B | – | +20.1% | +44.5% | +105.5% | |
| TTM EBITDA | $5.46B | +4.4% | +20.2% | +63.1% | +66.5% | |
| Price | $310.81 | +21.6% | +6.8% | +65.9% | +159.9% | |
| PE Ratio | 23.11 | +17.8% | -22.8% | +1.2% | – | |
| Quarterly Revenue | $84.75B | +8.2% | +5.1% | +26.6% | +58.7% | |
| Quarterly EPS | $3.94 | -53.1% | +11.8% | +67.8% | +181.5% | |
| $1.20B | -10.8% | +21.7% | +111.4% | +20.6% | ||
| Quarterly Net Income | $776.67M | -52.3% | +12.6% | +62.1% | +162.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.60B | -8.2% | |
| 3Y | $1.60B | -8.2% | |
| 5Y | $1.60B | -8.2% | |
| All | $1.60B | -8.2% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.12B | +32.0% | |
| 3Y | $789.04M | +86.7% | |
| 5Y | $722.10M | +104.0% | |
| All | $22.60M | +6416.5% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of COR?
- As of today, COR quarterly EBITDA is $1.47B
- What is COR quarterly EBITDA most recent change?
- COR quarterly EBITDA was down -8.21% on June 30, 2026
- What is 1-year change in COR quarterly EBITDA?
- COR quarterly EBITDA is up +18.60% year-over-year
- How far is COR quarterly EBITDA from its all-time high?
- COR quarterly EBITDA is currently -8.21% below its historical high of $1.60B set on March 31, 2026
- How does COR quarterly EBITDA rank versus sector peers?
- COR quarterly EBITDA is higher than 97.51% of companies in Healthcare sector
- When is COR next earnings release?
- The next earnings release for COR is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$5.46B$230.98M+4.42%
Summary
- Current Value
- As of today, COR TTM EBITDA is $5.46B, up +4.42% on
- Historical Performance
- COR TTM EBITDA is up +20.19% year-over-year, up +63.13% over the past 3 years
- All-Time High Comparison
- COR TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- COR TTM EBITDA is +63.13% above its 3-year low of $3.35B reached on an earlier date
- Sector Comparison
- COR TTM EBITDA is higher than 97.61% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $5.46B | +4.4% | +20.2% | +63.1% | +66.5% | |
| Annual EBITDA | $4.98B | – | +20.1% | +44.5% | +105.5% | |
| Quarterly EBITDA | $1.47B | -8.2% | +18.6% | +74.7% | +31.1% | |
| Price | $310.81 | +21.6% | +6.8% | +65.9% | +159.9% | |
| PE Ratio | 23.11 | +17.8% | -22.8% | +1.2% | – | |
| TTM Revenue | $332.77B | +1.2% | +5.1% | +30.8% | +62.9% | |
| TTM EPS | $13.45 | +3.2% | +38.4% | +64.0% | +173.0% | |
| $4.40B | +5.1% | +27.1% | +77.2% | +54.9% | ||
| TTM Net Income | $2.64B | +3.4% | +38.3% | +56.9% | +170.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $5.46B | at high | |
| 3Y | $5.46B | at high | |
| 5Y | $5.46B | at high | |
| All | $5.46B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.54B | N/A | +20.2% |
| 3Y | $3.35B | N/A | +63.1% |
| 5Y | $3.28B | N/A | +66.5% |
| All | $24.40M | >+9999.0% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of COR?
- As of today, COR TTM EBITDA is $5.46B
- What is COR TTM EBITDA most recent change?
- COR TTM EBITDA was up +4.42% on June 30, 2026
- What is 1-year change in COR TTM EBITDA?
- COR TTM EBITDA is up +20.19% year-over-year
- How far is COR TTM EBITDA from its all-time high?
- COR TTM EBITDA is currently at its all-time high
- How does COR TTM EBITDA rank versus sector peers?
- COR TTM EBITDA is higher than 97.61% of companies in Healthcare sector
- When is COR next earnings release?
- The next earnings release for COR is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- COR Official Website www.cencora.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1140859/000114085925000131/0001140859-25-000131-index.htm
- COR Profile on Yahoo Finance finance.yahoo.com/quote/COR
- COR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cor
